Stock Analysis

Have Insiders Sold CellaVision Shares Recently?

OM:CEVI
Source: Shutterstock

Some CellaVision AB (publ) (STO:CEVI) shareholders may be a little concerned to see that the Founder & Director, Christer Fahraeus, recently sold a substantial kr27m worth of stock at a price of kr274 per share. However, that sale only accounted for 5.8% of their holding, so arguably it doesn't say much about their conviction.

See our latest analysis for CellaVision

CellaVision Insider Transactions Over The Last Year

In fact, the recent sale by Christer Fahraeus was the biggest sale of CellaVision shares made by an insider individual in the last twelve months, according to our records. That means that an insider was selling shares at around the current price of kr264. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volume
OM:CEVI Insider Trading Volume September 1st 2024

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

Does CellaVision Boast High Insider Ownership?

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. It appears that CellaVision insiders own 7.3% of the company, worth about kr460m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Do The CellaVision Insider Transactions Indicate?

An insider sold CellaVision shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. But since CellaVision is profitable and growing, we're not too worried by this. The company boasts high insider ownership, but we're a little hesitant, given the history of share sales. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. While conducting our analysis, we found that CellaVision has 1 warning sign and it would be unwise to ignore it.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.